Chromium Picolinate

by Thorne Research

Chromium is an essential nutrient which enhances sensitivity to and improves utilization of the most important hormone of cellular energy and metabolism: insulin.

When not present in adequate amounts, dietary deficiencies of chromium may lead to inefficient use of insulin and poor glucose metabolism.

Research has indicated that insulin absorption by muscle cells was enhanced more by chromium picolinate. Chromium has also been reported to increase lean body mass and decrease body fat in some, but not all, people using it. The suspected mechanism behind chromium reducing body fat is that inefficient use of insulin by the body can lead to high blood glucose concentration which eventually signals the body to store these extra calories as fat.*

Current research also suggests that chromium supplementation may be beneficial to the cardiovascular system by balancing cholesterol levels.* Other studies have indicated that chromium supplementation increases HDL (good) cholesterol, thus countering the effects of increased LDL and decreased HDL cholesterol, therefore, supporting cardiovascular health.*

Chromium is Safe
Some years ago, a few poorly designed studies were reported to raise questions about the safety of chromium supplements. However, a review of scientific studies of chromium picolinate by the Institute of Medicine found no safety concerns for chromium at any of the amounts used. John Hathcock, PhD, vice president, scientific and international affairs of the Council for Responsible Nutrition commented, "This review included human studies of supplemental chromium (as chromium picolinate) up to 1000 micrograms per day and there were no observed adverse effects from intake of chromium, hence chromium picolinate is safe."

Other Ingredients: Aspartic Acid, Hypromellose (derived from cellulose) capsule. May contain one or more of the following hypoallergenic ingredients to fill space – Leucine, Silicon Dioxide.

(-) There is no %DV or the manufactuer has not provided this data.